|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current assets | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Short-term investments | ||||||||||||||||||||
| Accounts receivable, less allowances of $155 and $167, respectively | ||||||||||||||||||||
| Inventories | ||||||||||||||||||||
| Assets held for sale | ||||||||||||||||||||
| Other current assets | ||||||||||||||||||||
| Current assets of discontinued operations | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Investments and long-term receivables | ||||||||||||||||||||
| Equity method investments | ||||||||||||||||||||
| Long-term receivables and other investments | ||||||||||||||||||||
| Property, plant and equipment—net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Other intangible assets—net | ||||||||||||||||||||
| Insurance recoveries for asbestos-related liabilities | ||||||||||||||||||||
| Deferred income taxes | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Assets of discontinued operations | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES | ||||||||||||||||||||
| Current liabilities | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Commercial paper and other short-term borrowings | ||||||||||||||||||||
| Current maturities of long-term debt | ||||||||||||||||||||
| Accrued liabilities | ||||||||||||||||||||
| Current liabilities of discontinued operations and Liabilities held for sale | ||||||||||||||||||||
| Discontinued Operations | ||||||||||||||||||||
| Disposal Group, Held-for-Sale, Not Discontinued Operations | ||||||||||||||||||||
| Total current liabilities of discontinued operations and Liabilities held for sale | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term debt | ||||||||||||||||||||
| Deferred income taxes | ||||||||||||||||||||
| Postretirement benefit obligations other than pensions | ||||||||||||||||||||
| Asbestos-related liabilities | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Liabilities of discontinued operations | ||||||||||||||||||||
| Redeemable noncontrolling interest | ||||||||||||||||||||
| SHAREOWNERS’ EQUITY | ||||||||||||||||||||
| Capital—common stock issued | ||||||||||||||||||||
| Capital - additional paid in capital | ||||||||||||||||||||
| Common stock held in treasury, at cost | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Total Honeywell Technologies shareowners’ equity | ||||||||||||||||||||
| Noncontrolling interest | ||||||||||||||||||||
| Total shareowners’ equity | ||||||||||||||||||||
| Total liabilities and shareowners’ equity | ||||||||||||||||||||
Loading...